House of Commons photo

Crucial Fact

  • His favourite word was quebec.

Last in Parliament November 2009, as Bloc MP for Montmagny—L'Islet—Kamouraska—Rivière-du-Loup (Québec)

Won his last election, in 2008, with 46% of the vote.

Statements in the House

Patent Act February 10th, 2005

Mr. Speaker, it is obvious there is no easy solution. Nevertheless, there are some possible actions I can suggest to my colleague.

The first is to significantly and effectively increase the money available for international aid, most particularly in the area corresponding to this bill. Internationally, Canada, which was one of the first counties to vote on this bill, should also be in the avant-garde and not the rear guard of international aid.

The second may appear to be a bit of a stretch, but I think it is actually very closely related. The bill splitting up the Department of Foreign Affairs and International Trade must be withdrawn. It is important not to create a distortion such that, in our trade policies, we would no longer consider the human aspects, the impacts, and the decisions we make on the international level. I think that would be an important idea to follow up on here.

Also, as quickly as possible, we must come up with a foreign affairs policy that integrates trade and diplomacy issues as well as questions of international aid, so there will be guidelines, so all departments know which way we want to go. The NGOs must also get much more support than they do now. For example, Doctors Without Borders works in the field and is often at a loss when they have drugs but not the people who can administer them, because the protocols and support do not exist, or because there are not enough nurses. Those are the kinds of steps we should be taking.

I will add one final point. Parliamentarians should go into the field and see what conditions are really like in Africa. When one returns from such a trip, it is impossible ever to forget the importance of having a bill such as the one before us. In addition, for a developed society like ours, we must devote a bigger share to international aid.

Patent Act February 10th, 2005

Mr. Speaker, I will briefly repeat what I said at second reading. This bill must be passed as soon as possible, since it will allow us to provide Africa with quality drugs as soon as possible and at a lower cost.

When all the parties helped pass this bill at second reading, it was in the months leading up to a possible election call. Collaboration in the House permitted the desired result to be achieved at that time. The intention was extremely good, although we will have to wait a bit longer for the results. We passed this bill at second reading, but at the same time, we did not necessarily provide the funding to go with the drug supplies.

When Africa receives the crates of drugs it needs to treat these kinds of diseases, it must also have the necessary infrastructure and staff. We have some work to do here, which is much more important than the aim of the amendment moved today. Be that as it may, the two amendments deserved to be adopted.

Let us hope that we will then be able to achieve a workable system as soon as possible to eradicate diseases such as AIDS, which is wreaking such devastation in Africa. New cases appear daily. The phenomenon has, unfortunately, become commonplace, and taken for granted in recent years. Major corrective steps need to be taken. It is always the same. We in the developing countries have better means to defend ourselves against such things as earthquakes and disease, for example.

In this case, we really needed to make changes to the matter of intellectual property in order to meet international objectives on this in order to help Africa. This has been a collaborative effort by both the R and D companies producing experimental drugs and the generic drug companies. The same collaboration took place here in the House. This is, everyone must admit, a rather rare occurrence. The R and D firms researching new drugs and the generic firms are locked in battle, and there are often serious clashes here as well, leading to some pretty sharp exchanges. In this instance, however, we all felt that the situation needed to be remedied as soon as possible. That is the purpose of the two amendments we are looking at now.

In fact, an oversight occurred in our rush to get the bill through. The senators kindly agreed to pass the bill regardless, so as to not hold up the process. Now we are making the correction in this first amendment.

The second amendment, is intended to assist business, small research firms in particular, which felt they were being penalized by the kind of fines that they occasionally had to pay. So we are correcting this situation as well. This is a definite advantage.

I therefore encourage everyone in the House to vote in favour of this bill as soon as possible, so that we may at last put the finishing touches on this legislative package that will enable us to provide the countries of Africa, generally the most disadvantaged countries in the world, with these drugs.

Let us also call upon the government to make some specific announcements as part of its next budget for companion actions. This must not be just a bill but rather an action plan that will make it possible to eradicate such diseases as AIDS and malaria from Africa. We have no right to leave these countries struggling with these diseases as they are at the moment.

Patent Act February 9th, 2005

Madam Speaker, I am pleased to see that the parliamentary secretary and I share the same view as regards the importance of the aerospace industry. This is obvious. However, last fall, the federal government, based on the minister's replies, was supposed to release a study on its policy. It is now February and the hon. member is talking about a policy paper, a background paper that is being prepared through a consultation process. I hope this document is available as quickly as possible.

The government's offer is a major factor in the decision by Bombardier's board of directors. However, the more general framework under which these investments will be made for the “C” series aircraft is also important. This is also true for all other investments, for small and medium size businesses in the aerospace industry, and for other sectors such as helicopter production, for example, and related industries. It is urgent that this policy be known. It is urgent that this consultation process be completed and that we get a clear message, as we did for example in the 1980s regarding the development of patent drugs, which generated an economic boom.

Can we get assurances that the government will release its study and, more importantly, that it will make an interesting offer to Bombardier, so that this issue can be settled as quickly as possible?

Patent Act February 9th, 2005

Madam Speaker, on November 17, 2004, a few months ago, I put a question to the Minister of Industry, encouraging him to move forward with his aerospace strategy. At that time, his answer was:

—we are moving ahead on a strategy and we will announce the strategy once we have completed discussions and negotiations... We are moving forward with an aerospace strategy, and we will do it in a timely manner.

We are still waiting for a strategy to be announced. All we have heard since was that, at least, an offer had been made by the government to find a solution to help Bombardier so that it could build its new aircraft. At least, in that respect, the Minister of Industry took action following the questions we had put.

However, this happened also after the Minister of Transport, who is the minister responsible for Quebec, made some sort of false statement in January, when he said that an offer had been made on January 13, even though that was not the case.

What is important now is ensuring that the government will reach an agreement with Bombardier. The project must go forward, while respecting the current distribution of jobs in Canada, with approximately 55% in Quebec. We must ensure that we do not lose this project to New Mexico, for example, because the federal government acted too slowly. I hope that the necessary efforts will be made, today, to make up for lost time and ultimately produce results.

This afternoon, I asked a question confirming that, last fall, Bombardier had been offered a $1.5 billion loan guarantee so it could build jets for Air Canada. Four months later, the letter of credit agreement is unconfirmed, uncertified and not applicable. Bombardier itself has to assume the cost of additional credit because of this. So this is a bad example of the reality in which we are living.

Can the government spokesperson reassure me that we are going to reach a solution quickly and that the thousands of jobs at stake are going to be saved? We have developed an aerospace industry, especially in Quebec, but elsewhere in Canada as well, which deserves our support, and which deserves assistance for research and development. We also need an approach that complements the efforts of the Quebec government and others.

Now that the employees in the Toronto area have said they do not want to renegotiate their contract with Bombardier, is that not a compelling reason for us to have an announcement as soon as possible? Such an announcement is necessary so that Bombardier's board can decide to construct its new aircraft and so that we can benefit from the economic spinoffs, which would be good to have.

Patent Act February 9th, 2005

Mr. Speaker, it is a pleasure to speak on this bill. First, a historical overview is important.

We must remember that Canada wanted a system that would allow for an industry researching new medicines, based in large part on a model adopted by Brian Mulroney's Conservative government. An agreement was reached with the research industry. As a result, if the government assured it stable conditions over a number of years, the industry would, in return, commit to investing in research. In fact, both parties kept their commitment, which allowed the establishment of a very sound research industry, particularly in Quebec.

In addition to the federal government's conditions, the Quebec government implemented proposals and ways to protect such medicines. Today, we see the numerous and significant spin-offs of this. In the greater Montreal area, many people are making a good living from this industry, thanks to generous salaries. This phenomenon has also spread to the Quebec City region.

Today, the bill before the House proposes to set aside what we call the linkage regulations, which corresponds to the compromise developed to create a balance between research companies developing new products, which have to invest significant funds to do so, and the generic companies copying drugs, which want to ensure their availability to the most people possible. The balance that we have tried to create is extremely fragile. In fact, for quite some time, each party, both the generic drug manufacturers and the manufacturers of new drugs resulting from indepth research, has been trying to ensure that the conditions regulating this sector are to its advantage.

I have been sitting on the Standing Committee on Industry, Sciences and Technology for two or three years, and my predecessors in the Bloc Québécois did so for 10 years. The fact of the matter is that we have always been confronted with the same reality. Whenever we are listening to the arguments by one side or the other, we find some parts acceptable and some questionable. Ultimately, one constant emerges: what is most detrimental to research and development is the desire for constant change. This has adverse consequences. In the drug manufacturing industry, competition can be seen not only between research companies, but also within the companies, according to the country where they are established. For example, in Canada, when the regulatory environment is changed, the head office in the United States or Europe stands to benefit if we make regular changes and let it be known that these changes will be detrimental to these research companies.

This is the case to some extent with the bill before us. It reflects the vision of the member who introduced it, which is that, whether the drugs are research-based or generic, tough competition among drug manufacturers should be encouraged in order to maintain prices at a minimum. But the bill overlooks an important consequence: this would very significantly disrupt the current job structure in the industry. I find it difficult to believe that this is an appropriate solution.

It is important that this debate be a public one. The public has to be aware of the consequences of the choices made by governments. In this sense, it would be interesting if all angles of dealing with the issue could be presented in this House.

At the same time, we in the Bloc Québécois obviously cannot support such an approach, as it would have too great a negative impact on the economy.

When we look at how drug pricing works in Canada, there are other solutions which have to be considered as well, to determine their relevance. The fact should also be taken into account that, at present, the Department of Industry, in cooperation with the Department of Health, is conducting consultations on a proposed amendment to the linkage regulations. These consultations are continuing until February 24.

We have already heard from the generic companies to the effect that they will reject the proposed amendments as drafted. It is possible that when the consultations and negotiations are over, by February 24 or a few days later, we will be able to reach a compromise solution. That is what I want. For the moment, that is where these companies stand.

As for the research-based companies, we do not yet know their official position. The proposed amendments to the linkage regulations may be acceptable to young companies just beginning to develop products.

However, they may not appeal to the older companies that have well-established products. The inverse may also be true. The analysis is not yet complete on that side.

Nevertheless, it must be said that many of the realities of pharmaceutical manufacturing do change over time. Thus, 25 years ago pharmaceuticals did not have the mission they have today, of prevention and insurance. For example, the cost of a drug to lower blood cholesterol rates, which the patient has to pay for, may seem significant, but the cost for society is much less than if it had to pay for surgery. There are financial costs and also human costs related to this.

Thus, it must be studied very thoroughly and very carefully. At present, I am leaning much more in favour of a approach that would try to ensure that the consultation being carried out by the departments of industry and health is done properly and done transparently enough that, in the end, if we do eventually amend the linkage regulations in a way that is acceptable to both parties, we will be resolving an important issue.

I do not think, however, that doing away with the linkage regulations today would solve anything. I am sure that there would be a great deal of opposition in this House against it. It would be worthwhile seeking the opinion of international experts who would not have to issue opinions on drug quality per se, but only on the economic impact of such a decision. This would enable us to see immediately that this was inappropriate for the economy of Quebec and of Canada in general.

There is so much being put into creating research structures for training academics, who must have opportunities available to them in the end. It would not be to the advantage of the people of Quebec and of Canada to become nothing more than consumers of the most economical drugs. We also need people who produce drugs, not just experimental drugs, but also generic drugs under reasonable conditions.

The linkage regulations have been through so much over the past 10 years that now we have identified the gaps and areas that need work. I do not think it is necessary to start from scratch. Instead we could see whether the government's proposed amendments are acceptable or not.

The most concrete example, albeit very complicated, that I can give is that during the creation of a new drug by a company, the generic company can ask for permission to reproduce the drug and the research company that created the drug can ask for an injunction. Under the current act and regulations, there can even be multiple injunctions, which means the generic product will never enter the market.

There may be a way to refine this so as to reach a solution that limits the number of injunctions that can be made. There will be a mechanism that will help continue to create jobs, which is what we want.

I hope this bill will not be passed by the House. It was tabled with many good intentions regarding the impact on the availability of cheaper drugs. However, when we look at all the data, the economic repercussions and the quality of the drugs, we realize that we have to make sure that this is handled properly.

We realize that other problems have surfaced because of online pharmacies. We realize that some prices of generic drugs in Canada are much higher than they should be while prices of drugs and research products are controlled on the market. We realize there are also implications for the provinces.

For all these reasons, I think the route proposed in the bill is not appropriate.

Aerospace Industry February 9th, 2005

Mr. Speaker, I remind the minister that Bombardier has already commenced delivery of the jets for Air Canada. The ball is now in the minister's court.

Does he intend to act responsibly and honour his commitment to Bombardier, announced with great fanfare on October 28? Enough time has already gone by.

Aerospace Industry February 9th, 2005

Mr. Speaker, on October 28, 2004, the Ministers of Industry, International Trade and Transport announced amid great fanfare that the government was providing financial guarantees of up to $1.5 billion to enable Bombardier to sell its regional jets to Air Canada. Although construction of the jets has already begun, the concrete terms of this loan guarantee have yet to be decided, and Bombardier is being left to its own devices.

Can the government tell us what it needs to get moving and finalize its loan guarantee? Some 13 planes have already been delivered to Air Canada.

Supply February 8th, 2005

Mr. Speaker, obviously the words of the hon. member for Saint-Maurice—Champlain are very eloquent. Here we have more than 50 people from the FTQ who have come from Montreal to bear witness to the situations they have faced or are now facing.

If the federal government wants to do something practical in the short term, quickly, to show that it is ready to treat these people fairly, in the coming budget there must be a program to help older workers.

When there is a surplus of $45 billion in the employment insurance fund, there must be a way to find a few hundred million dollars using the premiums these people have paid. It is not the federal government's money; it is money that was taken from the pockets of these workers in order to pay for something other than what they were paying premiums for. Now it is time to treat them with justice.

Supply February 8th, 2005

Mr. Speaker, I thank the hon. member for his question.

The first thing we observe is that the closures occur mainly in Quebec and Ontario. The Gildan announcement was a very sad one, and others may follow elsewhere.

Another important aspect is the fact that the people who work for these companies are often long-standing employees, with 20, 25 or 30 years of service. In 1995, the federal government abolished a program designed to province financial assistance to older workers as they moved toward retirement. We have been trying ever since to reintroduce this program in the employment insurance plan. Today, this is even more important.

The textile and apparel industries need a sound assistance program, but we have to expect job losses as the ones we see right now. These people who contributed to our society for 20, 25, 30 or 35 years have earned the right to be acknowledged. This program should be reinstated as soon as possible. Not only is there a need for it in the short term, but also more and more workers will be impacted by the new realities of market globalization and international competition.

In Montmagny, over one hundred workers aged 55 or over are in a difficult situation right now. They need as much opportunity as possible to get back into the work force, through active measures, but the reality is that a good number of them will not get other jobs. They deserve, not passive measures, but a program that would get them through to retirement age.

If a decent reserve had been maintained in the EI fund in the past few years, the federal government would be the first to come up with such a program. But that money has been used for purposes other than those for which employees and employers paid into the fund.

These workers, most of whom are women, absolutely need some help to overcome this obstacle. Active measures are needed, but so is a program of passive measures that will enable people to earn an income until they retire. Such is their reality. Efforts must be made to ensure that lay-offs are kept to a minimum. When people are laid off, every effort must be made to ensure that workers who have devoted their lives to the company can benefit from the appropriate measures. This is a very important goal.

Department officials who came before the Standing Committee on Industry, Natural Resources, Science and Technology told us that the total economic activity would not be so seriously affected. But the reality is that whole communities are being hit very hard, Huntingdon in particular, which my colleague will be speaking about shortly. Similar jobs have been lost in my area, in Montmagny, as well as elsewhere. In Cowansville, Consoltex is about to experience job losses if steps are not taken promptly. If this does come to pass, those communities will be hard hit.

This is the reason the federal government must take steps to complete its intervention plan as recommended. I hope that the House will support that recommendation unanimously this evening. It is essential for the clothing and textile industries.

Supply February 8th, 2005

Mr. Speaker, I welcome this opportunity to speak in this debate on the Bloc Québécois motion to help the clothing and textile industries. I will be sharing my time with the hon. member for Beauharnois—Salaberry, who represents the region of the municipality of Huntingdon, which has unfortunately been dealt a direct blow because of the federal government's failure to act. He will be able to describe it better than I can.

This motion arose from the experience of many of our ridings. When we think of companies like Consoltex Holdings and Bermatex in Montmagny, Confection 131 in Saint-Pacôme, Confection M.P.M. in Sainte-Perpétue, Élastiques Qualités Ltée and Calko Canada in Rivière-du-Loup, we realize that all types of production are represented in the textile and apparel industry.

There is great discontent everywhere with the announcement the federal government made in a panic right after the announced closures in Huntingdon to try to appease the resultant unrest. The government announced an incomplete action plan in which several important components are missing.

On December 17, following the government's announcement, the Canadian Textiles Institute, through its CEO, Harvey Penner, wrote a letter to the Prime Minister, listing what was missing in the government's plan.

That is what prompted the Bloc Québécois to present this motion, which I would like to read again:

That the House acknowledge the inadequacy of the assistance plan for the clothing and textile industries which was announced by the federal government following the closure of six plants in Huntingdon, and that it ask the government to further elaborate with regard to the following elements: the use of safeguards provided for in trade agreements, the implementation of measures to encourage the use of Quebec--and Canadian--made textiles and the creation of a program to assist older workers.

We hope that the House will support this motion. We are sending the federal government the very clear message that its current action is inadequate. It ought to proceed with further action.

I will quickly explain the very concrete proposals made by the Canadian Textiles Institute. First, the decision made by the federal government to lift the quotas and custom duties on textile imports for the least developed countries was a good measure. However, some adjustments should have been made, particularly as regards the rule of origin to the effect that, clothing produced in a developing country, in one of the world's poorest countries, can be imported to Canada.

However, the Americans have a rule that the textiles used must be from the United States, whereas Canada does not have such a rule. This is rather hard on our textile industry. The president of the Canadian Textiles Institute made the following comment:

—This was one of the main recommendations that we made to your ministers and public servants, but Tuesday's announcement totally ignored these recommendations.—

The first conclusion is that the federal government ignored that recommendation by the textile industry.

The second remark has to do precisely with the fact that the U.S. government signed a series of agreements with various countries, particularly Caribbean countries, to apply the rule to which I referred earlier, namely that textiles produced in the United States are sold to those Caribbean countries, which make and finish clothing, which then returns to the United States market.

If the textiles used to make the clothes do not come from the United States, the products cannot be exported there. This practice violates NAFTA, since that agreement created a free trade zone. However, the Americans have found a way of circumventing the rules.

I hope that the next time the Prime Minister of Canada, President Bush and President Fox of Mexico meet, this issue will be on the agenda, so that Mexico may be asked to have the same type of arrangement, or the rules may be the same for everyone. Currently, this way of doing things contributes to the closure of our textile mills.

This morning, an article by Hélène Baril in the daily La Presse clearly stated, “The Canadian textile industry ousted by the American market.” This is one of the fundamental reasons there are fewer employees at textile mills and mills are being closed. So, we must be able to counter this measure. Here again, the head of the Canadian Textiles Institute said that “We need a plan B to restore our share of the American market”.

This point was raised on numerous occasions with ministers and staff. However, it was never addressed in the announcement. So, in the plan introduced on the day before, that is, December 16, there was no confirmation either that anything would be done to fix this. This was the second serious measure on which recommendations were made to the federal government. Recommendations were not just made on December 17, but during the previous months. I have proof of this in a letter sent to me, which presented the government with a complete plan several months prior.

This aspect is also missing from the government's position. So, there are serious problems.

The letter sent to the Prime Minister indicates, and I quote:

A program, which would allow apparel imports to be duty-free if they were made using Canadian textiles, would allow us to expand our export market and would open the doors to new foreign clients, who would doubtless have an interest in buying our products. We recommended such a program to your ministers and your officials and we were disappointed to see that this measure was not included in the announcement.

So, the textile industry strongly condemns the action plan released in such a hurry as totally unsuitable. It would take a second wave as soon as possible to counter the negative effects. Jobs are disappearing one after another. Again last week, representatives of Gildan Activewear made the candid admission that their decision was the result of not having access to the American market and that access to the American market needed to be found. Businesses are not trying to circumvent legislation. They are struggling with the regulations and the legislation. They want a suitable legislative framework, which they do not currently have. The assistance packages announced are clearly insufficient.

I think we also need very positive measures such as labelling. In order for consumers to make wise choices, they need to know exactly where products were made, by whom and in what conditions. For instance, in the suit I am wearing right now there is a label saying “made in Canada“. Nowadays, when we make purchases, we are aware of those things. However, many products are not clearly labelled. In addition, in the case of many products, only the last steps of production take place in Canada. We ought to know about the whole chain of production because, as consumers, each of us has a responsibility in that regard.

Today's motion calls on the federal government to do more. As consumers, we have certain responsibilities to help industries function properly, but the government has to send a clear message to that effect.

It is also important to put aside the suggestion made by the federal government that it is better not to do anything for the apparel and textile industry, implying that, over time, the jobs lost will be replaced by others, in different industries.

The textile industry can have a future. The federal government should move forward and help this industry develop, and it should promote research and development through Technology Partnerships Canada. To this day, this program has been used to help the new economy. Great, but there are traditional industries where the federal government should invest, such as the furniture industry—even if we are dealing today with the clothing and textile industry. Textiles can include geotextiles, for example. And there is a future in health care too, where textiles could be used with drugs. The potential is there, but we should invest in research and development. Unfortunately, that is not an option right now.

In short, this program is inadequate. The clothing industry knows the measures that have been implemented, but we are still waiting for the Canadian International Trade Tribunal to go through with what the government has announced in December. With each passing day and month, with nothing being done, companies affected by this decision of the tribunal are losing money, becoming less competitive and less able to face the situation they are in.

To conclude, I met people from the clothing and textile industry at a seminar of exporters and manufacturers. The clothing industry would like the measures that have been announced to be implemented so they can have an impact. But for the textile industry, a whole section of the program is missing.

Hopefully, tonight, when we vote on this motion, a majority will send a clear message to the federal government: “Do your homework again and finish what you have started. If you do not move, you will be responsible for the demise of an industry that provides a lot of jobs in Quebec, and these jobs will be lost if the federal government does not do something soon.”